Regulatory Activity Forums (2) |
Guidance Document Forums (4) |
Description of Changes / Guidance Documents Being Changed | Boards Affected By This Forum | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Department of Health Professions (Agency 223) | ||||||||||||||||||||||||
View and Enter Comments |
Update of agency guidance documents consistent with internal, non-substantive changes since 2020
0 Comments
Closes: 7/16/25
|
Board of Pharmacy | ||||||||||||||||||||||
View and Enter Comments |
New guidance document 110-20 adopted by Board to address HB2378 of the 2025 General Assembly Session regarding therapeutically equivalent drug products.
0 Comments
Closes: 7/30/25
|
Board of Pharmacy | ||||||||||||||||||||||
View and Enter Comments |
Amendment of Guidance Document 110-34 to update references to current criminal background check procedures and eliminate obsolete language and links.
0 Comments
Closes: 7/30/25
|
Board of Pharmacy | ||||||||||||||||||||||
View and Enter Comments |
Amendment of Guidance Document 110-44 to address expansion of protocol to other opioid antagonists and other individuals who may administer opioid antagonists pursuant to legislation from the 2024 and 2025 General Assembly.
0 Comments
Closes: 7/30/25
|
Board of Pharmacy |